
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp is positioned for a positive financial outlook, demonstrating a robust performance in its Cardio & Vascular segment, with a revenue increase of 15% in the recent quarter. The company anticipates sustained growth driven by upcoming product launches targeted for 2H26/2027, alongside projected operating margin improvements and stable gross margins expected to reach 27.3% in 2025E. Additionally, strong operating cash flow projections, increasing from $205 million to a forecasted $230-$240 million, will support lower leverage ratios, while the overall cardiovascular device market remains favorable, underpining Integer’s growth potential amidst industry headwinds.
Bears say
Integer Holdings Corp is experiencing a downward revision in revenue forecasts, with 4Q25E revenues adjusted to $460.0 million, reflecting only a 2% increase year-over-year and a reduction from previous estimates. The company has lowered its full-year 2025 revenue guidance to a range of $1,840 million to $1,854 million, indicating a lack of growth momentum and dampened prospects due to lower demand for key products. Additionally, the company's initial outlook for 2026 suggests further challenges, with anticipated headwinds from a slower-than-expected market adoption of newer product launches, contributing to a projected decline in adjusted operating income.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares